BioSpace News Archive

Biotech Beach

Dr. Todd Lanman Begins Breakthrough Low Back Total Joint Replacement Clinical Trial in Beverly Hills with 3Spine, Inc.

Todd Lanman, MD and Lanman Spinal Neurosurgery announced completion of the first lumbar total joint replacement procedure in California as part of a pivotal clinical trial sponsored by 3Spine, Inc.

March 21, 2023
·
4 min read
Policy

FDA Roundup: March 21, 2023

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

March 21, 2023
·
2 min read
Business

Y-mAbs to Announce 2022 Financial and Operating Results on March 30, 2023

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that it will report its financial results for year ended December 31, 2022, on Thursday, March 30, 2023, after the close of the U.S. financial markets.

March 21, 2023
·
4 min read
Business

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results

Hyperfine, Inc. announced fourth quarter and full year 2022 financial results and provided a business update.

March 21, 2023
·
13 min read
Business

Minerva Surgical Announces the Appointment of Kaile Zagger as Chief Commercial Officer

Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical), a women’s health company focused on solutions to meet the distinct uterine healthcare needs of women, announced today the appointment of Kaile Zagger as its new Chief Commercial Officer.

March 21, 2023
·
4 min read
Business

AcelRx to Host Full Year and Fourth Quarter 2022 Financial Results Call and Webcast on March 30, 2023

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX) today announced that it will release full year and fourth quarter financial results for 2022 after the market close on Thursday, March 30, 2023.

March 21, 2023
·
2 min read
Business

Navidea Biopharmaceuticals Reports Fourth Quarter 2022 Financial Results

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced its financial results for the three-month and twelve-month periods ended December 31, 2022.

March 21, 2023
·
11 min read
Biotech Beach

RadNet, Inc. to Present at the Sidoti & Company 2023 Virtual Spring Investor Conference on Wednesday, March 22nd

RadNet, Inc. (NASDAQ: RDNT) today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Sidoti & Company Spring 2023 Conference on Wednesday, March 22nd at 01:00 p.m. Eastern Time.

March 21, 2023
·
1 min read
Business

Emmes Acquires Essex Management

Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced the acquisition of Essex Management.

March 21, 2023
·
3 min read
AtomVie Global Radiopharma Inc. presents at key investor conferences

AtomVie Global Radiopharma Inc. is pleased to announce that it has been selected among the presenting companies and will be available for 1 on 1 meetings at the following upcoming key investor conferences.

March 21, 2023
·
2 min read